ArticleJournal of diabetes investigation2021

Sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice.

Taro Hirai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.